PharmaCorp Rx Inc. (TSXV:PCRX)
Canada · Delayed Price · Currency is CAD 0.4700
-0.0050 (-1.05%)
Sep 3, 2026, 2:20 PM EST
PharmaCorp Rx Market Cap
PharmaCorp Rx has a market cap or net worth of CAD 81.82 million as of September 4, 2026. Its market cap has increased by 45.32% in one year.
Market Cap
81.82M
Enterprise Value
62.62M
Revenue
27.41M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.47
ChartMarket Cap Chart
Since September 29, 2022, PharmaCorp Rx's market cap has increased from 2.40M to 81.82M, an increase of 3,309.10%. That is a compound annual growth rate of 145.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2026 | 81.82M | 7.72% |
| Dec 31, 2025 | 75.95M | 19.91% |
| Dec 31, 2024 | 63.34M | 427.83% |
| Dec 30, 2022 | 12.00M | 400.00% |
| Sep 29, 2022 | 2.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Apotex Health | 7.45B |
| Extendicare | 2.83B |
| Green Thumb Industries | 2.28B |
| Sienna Senior Living | 2.26B |
| Zentek | 92.43M |
| Covalon Technologies | 82.85M |
| Leef Brands | 80.97M |
| ME Therapeutics Holdings | 75.97M |